‘Delisting’ OxyContin® to reduce prescription opioid-related harms in Ontario (Canada)-gauging effects 5 years later-Reference-Cited by-同舟云学术

‘Delisting’ OxyContin® to reduce prescription opioid-related harms in Ontario (Canada)-gauging effects 5 years later

Author:

Fischer Benedikt¹²³⁴^ORCID,Vojtila Lenka¹,Kurdyak Paul¹²⁵⁶

Affiliation:

1. Institute for Mental Health Policy Research; Centre for Addiction and Mental Health (CAMH); Toronto Canada

2. Department of Psychiatry; University of Toronto; Toronto Canada

3. Institute of Medical Science; University of Toronto; Toronto Canada

4. Centre for Criminology and Socio-legal Studies; University of Toronto; Toronto Canada

5. Health Outcomes and Performance Evaluation Research Unit; Centre for Addiction and Mental Health (CAMH); Toronto Canada

6. Mental Health and Addictions Research Program; Institute for Clinical Evaluative Sciences; Toronto Canada

Funder

Canadian Institutes of Health Research

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference42 articles.

4. Trends in opioid analgesic abuse and mortality in the United States;Dart;N Engl J Med,2015

5. Current state of opioid therapy and abuse;Manchikanti;Curr Pain Headache Rep,2016

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献